The hospital was turned into a containment zone after 26 nurses and 3 doctors tested positive for Covid-19.
The impact on revenue for private hospitals is expected to last for the next two quarters, ICICI Direct said in a note. For some hospitals, the drop in patients from overseas is a concern.
Molecular diagnostics companies have expressed concern after the government on Saturday decided to ban export of all diagnostic kits and reagents.
IPCA Labs, Zydus Takeda, Mangalam Drugs & Organics and Wallace Pharma are among the manufacturers of this drug that are staring at fluctuating freight rates, a jump in prices of bulk drugs from Chinese suppliers and an erratic supply chain with cancelled or reduced frequency of cargo flights.
ICMR said in an interim advisory that antibody tests can be carried out in hotspots – zones suspected to have widespread prevalence of the disease. Those testing positive for antibodies will be made to do RT-PCR tests, which can reveal the presence of virus, and will be quarantined at home.
The US-based Thermo Fisher Scientific, Germany's Siemens and Altona, and South Korea's Seegene are all expected to start supplying Covid-19 test kits this week, people aware of the development told ET.
Several private labs say they are stuck between following state government directives and ICMR guidelines, such as home collection of samples. This is allowed by the ICMR, which also lists 16,000 collection centres across the country. However, some states have banned home collection & have even stopped labs from conducting tests at their own facilities.
Mumbai-based BDR Pharma, which makes anti-HIV and Hepatitis C medication, and LASA Supergenerics, an active pharmaceutical ingredient maker, are betting that the drug works. While BDR has started lab work to get the initial samples out, it has several hurdles to cross before the product hits the market, the biggest being getting the actual reference product shipped from China.
The idea of the project will be to respond and mitigate the Covid-19 threat and strengthen national systems for public health preparedness in India, as per the project document.
The revised clinical management guideline for Covid-19 management says that no specific antivirals have been proven to be effective as per currently available data.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon